It has been reported that patients with LC who achieve SVRs with DAA therapy show improvements in liver function and fibrosis, with improvements in aspartate transaminase levels, alanine transaminase levels, serum albumin levels, type IV collagen levels, and the fibrosis-4 index [21,22]. Here, ALB is linked to laryngotracheoesophageal cleft.